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Session: Regenerative Medicine 107also be involved in the physiological and pathological process of articular
cartilage.
http://dx.doi.org/10.1016/j.jot.2016.06.116349
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Introduction: Wrist chondral defect is a common cause of persistent joint
pain, which may lead to functional impairments including reduced range of
motion and diminished grip strength, affecting working ability and quality
of life. There are various reported surgical treatment regimens but their
effectiveness remains controversial due to the inherently poor regeneration
ability of cartilage. Bone marrow-derived mesenchymal stem cells (MSC) are
reported extensively to promote the regeneration of articular cartilage in
various chondral defect and osteoarthritis animal models. While translation
studies are on-going in knee OA, it is of clinical interest to explore the poten-
tial effectiveness of MSC therapy for the treatment of wrist chondral defect.
As the first local MSC trial for chondral defect, we aimed to examine the
feasibility and the safety, and to obtain data for sample size estimation for
future study.
Subjects and methods: In this phase I single-arm trial, 10 patients (18 to 75
years old) with persistent post-traumatic chronic wrist pain, with imaging
and previous arthroscopic evidence of wrist carpal bone chondral defects
who opted for active treatment were invited to join (CREC Ref No. 2014.291-
T). After arthroscopic washout and debridement, 10mL bone marrow was aspi-
rated and subjected to the isolation and expansion of MSC cells in a certified
clean room (ISO class 7). The MSC was characterized with a colony forming
unit (CFU) assay, surface phenotypes (CD45, CD14, CD19, CD34, CD73, CD105,
CD44, CD29, CD90, and HLA-DR), and a multipotent differentiation assay ac-
cording to the International Society for Cellular Therapy guidelines. One month
after bone marrow aspiration, characterised autologous MSCs (1 million cell per
mL saline) with viability over 90% and clean from microbiological tests were
injected back into the wrist joint of the patient. One-year follow-up assess-
ments including functional wrist performance score and pain score, and other
secondary assessments were carried out by trained personnel. The spread of
data was tested for normality. Changes from baseline (pre-op) in all the mea-
surements were determined with a t-test or Wilcoxon sign rank test where
appropriate. Missing data was replaced with imputation under a missing-at-
random assumption. Differences were considered statistically significant when
p < 0.05 (SPSS V19).
Results: Six patients (5 male and 1 female), mean age of 38.5 years old fulfilling
the inclusion and exclusion criteria were recruited during the reported period
(January to December 2015). All procedures, including bone marrow aspiration,
arthroscopic debridement, and intra-articular MSC injection, were uneventful
and there were no signs of infection and nil complications noted or
reported. It was practical to expand MSCs in vitro to a sufficient number for
characterisation and injection in one month. Till now, six-month follow up
data indicated the potential therapeutic effect of intra-articular MSC injection
at single dose, as shown by numerical improvement in performance score and
pain score.
Discussion and conclusion: This pilot clinical trial shows the safety and potential
therapeutic effect of single dose autologous bone marrow-derived MSCs on persis-
tent wrist chondral defect. Additional data from the second phase follow-up will
provide more insight into the treatment of wrist chondral defect with MSCs.
http://dx.doi.org/10.1016/j.jot.2016.06.117358




Ground state porcine induced pluripotent stem cells (piPSCs), which retain the
potential to generate chimeric animal and germline transmission, are difficult to
produce. This study investigated morphological and biological progression at the
early stage of porcine somatic cell reprogramming and explored suitable
conditions to increase the induction efficiency of piPSCs. A cocktail of defined
transcription factors was used to generate piPSCs. The amphotropic retrovirus,
which carried human OCT4 (O), SOX2 (S), KLF4 (K), C-MYC (M), TERT (T), and
GFP were used to infect porcine embryonic fibroblasts (PEFs). The number ofclones derived from OSKM (4F) and OSKMT (4F + T) was significantly higher than
that from SKM (3F) and SKMT (3F + T), suggesting that OCT4 played a critical role
in regulating porcine cell reprogramming. The number of alkaline phosphatase
positive clones from a medium with leukaemia inhibitory factor (LIF) and basic
fibroblast growth factor (bFGF) (M1 medium) was significantly higher than that
with insulin and 2i PD0325901/CHIR99021 (M2 medium), indicating that insulin
and 2i could not effectively maintain piPSC propagation. In the M1 medium,
piPSC lines could not maintain the typical self-renewal morphology on gelatin-
coated and Matrigel-coated plates. Without the mouse embryonic fibroblast
(MEF) feeder, piPSCs started to simultaneously differentiate. Based on the
potential for self-renewal and activation of pluripotent markers, we found that
the culture condition of 4F + T plus LIF and bFGF plus MEF feeder promoted PEF
reprogramming more efficiently than the other conditions tested. Two
piPSC lines (IB-1 and IB-2) were derived and maintained for up to 20 passages
in vitro.
http://dx.doi.org/10.1016/j.jot.2016.06.118405
INJECTABLE AND ROBUST BIOPOLYMER-BASED SUPRAMOLECULAR HYDROGELS
FOR REGENERATIVE MEDICINE
Liming Bian, Kongchang Wei, Qian Feng
The Chinese University of Hong Kong, Hong Kong
Osteoarthritis (OA), which is symptomised as progressive degradation of
articular cartilage in human diarthrodial joints, has become one of most
prevalent, debilitating diseases in modern society. To address the increasing
clinical demand for more effective treatment of OA, significant progress has
been made in biotechnology, especially in the field of biomaterials. In the most
recent decade, increasing research emphasis has been placed on the “bio” part
of biomaterials. In our lab, we have shown that functionalisation of the
hydrogels with biomimetic peptides promotes the differentiation of the hMSCs.
In addition to the biofunctionalisation, the physical functions of the bio-
materials are also critical to the successful translation of biomaterials to
clinical treatment of cartilage diseases. Although biopolymer-based chemical
hydrogels, with biopolymers covalently crosslinked, have been widely used as
scaffolds for tissue engineering due to good stability, their permanent network
structures and brittleness limit their applications in repairing load-bearing
tissues, such as cartilage. In contrast, biopolymer-based supramolecular hydro-
gels, which are usually formed via self-assembly of physically interacting
biopolymers are usually weak, as shown in “inverted vials”, instead of
freestanding 3D constructs and they are less stable than chemical hydrogels.
Herein, we describe a novel host-guest macromer (HGM) approach for prepa-
ration of biopolymer-based freestanding supramolecular hydrogels. We have
developed a series of injectable hydrogels with unique properties such as
resilient mechanical property, bioadhesiveness, injectability, and promoting
recruitment of endogenous cells that are desirable for potential clinical
applications in the regeneration of soft musculoskeletal tissues such as
cartilage, meniscus, and intervertebral discs.
http://dx.doi.org/10.1016/j.jot.2016.06.119410
CO-CULTURE OF HUMAN SYNOVIUM-DERIVED STEM CELLS AND
CHONDROCYTES REDUCES HYPERTROPHY
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Introduction: Mesenchymal stem cells (MSCs) have emerged as a clinically relevant
cell source for regenerative medicine, especially for cartilage repair; however, it
still remains a challenge to recapitulate the functional properties of native artic-
ular cartilage using only MSCs. In vitro expansion of chondrocytes causes dediffer-
entiation. Lately, co-cultures of chondrocytes and bone marrow MSCs
demonstrated enhanced functional properties of engineered cartilage. In this
study, we aimed to assess the effect of co-culture of synovium-derived stem cells
(SDSCs) and chondrocytes on in vitro chondrogenesis in serum-free TGF-b supple-
mented medium.
Methods: Isolation and expansion of cells: Human SDSCs and chondrocytes were
isolated by sequential digestion from explants of total knee arthroplasty patients
and incubated at 37 C, 95 % humidity, and 5 % CO2 in standard culture medium. We
used passage 2 cells hereafter.
In vitro differentiation of cells: Expanded chondrocytes, SDSCs, and chondrocyte/
SDSCs (5105cells per pellet; co-culture ratio, 1:1) were cultured in chondrogenic
medium for 1, 7, 14, and 21 days. The SDSC and chondrocyte/SDSC mixed pellets
were cultured with the supplementation of 10 ng/mL of TGF-b1 and the chondro-
cyte pellets were cultured in chondrogenic medium only. The medium was
changed twice per week.
108 Session: Regenerative MedicineDetermination of glycosaminoglycan (GAG) content: The synthesised GAG was
determined by binding to DMB dye and the total amount of GAG was normalised to
the amount of DNA by a PicoGreen dsDNA assay.
mRNA expression assay: Expressions of type I, II, X collagen, SOX-9, and aggrecan
were analysed by real-time PCR. Expression of GAPDH was taken as an internal
control.
Histologic and immunohistochemical examination: Pellets from each time point
were stained with H&E and safranin-O for proteoglycan detection. The expression
of type II collagen was detected by immunohistochemical (IHC) staining.
Results: Co-culture of human SDSCs and chondrocytes exhibited significantly
higher GAG synthesis and type II collagen content. Furthermore, expression of
type X collagen, a marker of MSC hypertrophy, was significantly lower in the co-
culture pellets. The co-culture groups exhibited up-regulation of type II collagen
and Sox-9 at seven days, and type I collagen, type X collagen, and aggrecan at
14 days. Safranin-O staining and IHC staining for type II collagen showed that chon-
drogenic differentiation of the co-culture group were higher than those of the
chondrocytes or SDSCs single culture groups.
Discussion: Our results demonstrated that mixed co-culture of SDSCs and chondro-
cytes reduced cellular hypertrophy and enhance in vitro chondrogenesis when
compared to the culture of chondrocytes or SDSCs alone.
http://dx.doi.org/10.1016/j.jot.2016.06.120414
THE EFFECT OF LEUKOCYTE DEPLETION IN PRP ON THE PROLIFERATION AND
CHONDROGENESIS OF SYNOVIUM-DERIVED MSCs AND EXPANDED
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Sahnghoon Lee, Hee Jung Park, Hyuk Soo Han, Bo Hyun Kim, Myung Chul Lee
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Introduction: Platelet-rich plasma (PRP) has been advocated as one treatment
strategy for cartilage tissue regeneration. To date, several different platelet-
rich formulations have been made available, but a deep knowledge of their compo-
sition and mechanism of action in a specific clinical use is needed. There are many
variations in PRP formulations, with both platelet and leukocyte concentrations
having been identified as major constituents affecting the inflammatory responses
after PRP injection. The aim of this study was to investigate the effect of leuko-
cyte depletion in PRP on the proliferation and chondrogenesis of synovium-derived
MSCs (SD-MSCs) and chondrocytes.
Methods: Preparation of PRP formulations: From donated human fresh blood, we
prepared three formulations of PRP: (1) platelet-poor plasma (PPP), (2) PRP with
very few leukocytes (P-PRP), and (3) PRP with high concentrations of both plate-
lets and leukocytes (L-PRP). PPP is the upper layer of plasma after centrifuging
10cc whole blood at 2400rpm for 10 minutes. After 2nd centrifuging at 3600rpm
for 15 minutes, P-PRP is the lower layer of plasma without buffy coat. L-PRP is
the lower layer of plasma with buffy coat.
Cell culture and in-vitro expansion: SD-MSCs and chondrocytes were obtained from
patients undergoing total knee arthroplasty. The primary cells were expanded in
DMEM with the three formulations. The cell proliferation was measured using
the MTT assay.
Chondrogenesis: Chondrogenic differentiation of SD-MSCs and expanded chondro-
cytes were induced using a high-density pellet culture system. Aliquots of 5105
cells were centrifuged at 500g for 5 minutes, which were subsequently cultured
for three weeks. The pellets of SD-MSCs and chondrocytes were cultured in chem-
ically defined chondrogenic medium with 10 ng/ml of TGF-b1 and/or 100 ng/ml of
BMP-2.
Real-time PCR: Total RNA from SD-MSCs and chondrocytes were extracted by using
the RNeasy mini kit (Qiagen). Expressions of type II collagen, type X collagen,
Aggrecan, and Sox9 were analysed by RT-PCR. Expression of GAPDH was taken as
the internal control.
Histological and immunohistochemical examination: Pellets were stained with
Safranin-O for proteoglycan detection. The expression of type II collagen was
detected by IHC staining and was observed under microscopy.
Results: Leukocyte depletion also lowered the count of platelets. L-PRP
showed more proliferative effect on SD-MSCs and chondrocytes than P-PRP.
RT-PCR revealed higher cartilage gene expression in TGF-b1 induced chondro-
genesis of SD-MSCs and chondrocytes with P-PRP. However, there was a nega-
tive effect of both formulations in TGF-b1/BMP induced chondrogenesis. In
TGF-b1 and/or BMP induced chondrogenesis, the SD-MSC pellet with P-PRP
showed more proteoglycan production than those with L-PRP. Type II collagen
synthesis in the chondrocyte pellets with P-PRP was greater than the pellets
with L-PRP. However, type II collagen synthesis in SD-MSCs pellets was not
detected.
Discussion: Although leukocyte depletion in PRP showed a negative effect on
proliferation of SD-MSCs and chondrocytes and a positive effect on the mRNA
expression of the chondrogenic differentiation marker genes, it could not
change the negative effects of PRP on chondrogenic differentiation of SD-
MSCs.
http://dx.doi.org/10.1016/j.jot.2016.06.121465
DIFFERENCES IN MORPHOLOGY, PROLIFERATION, DIFFERENTIATION AND
IMMUNE PROFILE AMONG SINGLE-CELL CLONED STEM CELLS FROM THE SAME
MESENCHYMAL STEM CELL ORIGIN
Yenwen Cheng, Sorousheh Samizadeh, Melanie Coathup, Gordon Blunn
University College London, United Kingdom
Introduction: Mesenchymal stem cells (MSCs) are believed to be immune-privi-
leged due to lack of antigen-presenting-cell related markers; however, evidence
suggests that MSCs are immunogenic and are attacked by the immune system.
Our research investigates the hypothesis that there are differences between MSC
clones from the same individual in terms of their morphology, proliferation, differ-
entiation, and immune profile. Our goal is to discover immune-privileged stem
cells, which can act as a universal allogenic mesenchymal stem cell donor to facil-
itate bone ingrowth for osteosarcoma patients’ status post tumour excision and
prosthesis implantation.
Subjects and Methods: Serial dilutions of bone-marrow derived (BMMSCs) and ad-
ipose derived mesenchymal stem cells (ADMSCs) from the same animal were car-
ried out in order to isolate single-cell clones. From a single animal we obtained
three clones from BMMSCs and three from ADMSCs. This procedure was repeated
for another two animals. The proliferation rate and cell doubling time of each
clonal culture was measured. The proliferation rate of mixed clonal cultures
was also measured. The tri-differentiation potential of the clonal cultures was
compared and a comparison was also made with the original isolates from bone
marrow and fat. The immune-privileged properties were measured by flow cytom-
etry and immuno-staining for the major histocompatibility complex (MHC) anti-
gens. To measure the immune response a mixed leucocyte reaction was used
but where leucocytes from a different individual were mixed with the clonal
MSC cells.
Results: All isolates were able to differentiate into osteoblasts, chondrocytes, and
adipocytes. All clonal cultures revealed significantly different proliferation rates
and doubling times when compared with each other and with mixed cultures. All
clonal cultures showed different surface marker presentations, which included dif-
ferences in the expression of MHC antigens. One clone isolated from ADMSCs
showed a lack of MHCI and MHCII. Our mixed leucocyte reaction and MHC staining
showed a variety of immune-modulation and this was related to the expression of
the MHC antigens.
Discussion and Conclusion: All clones tri-differentiated and therefore show a
degree of ‘stemness’. MSCs are generally believed not to express MHCII and to
be immune-privileged. However, this study shows that the expression of these
antigens in clones isolated from bone marrow and from fat is variable. A het-
erogeneous result indicates individual differences between MSCs, even from
the same origin. The immune response elicited by MSCs is complicated.
MSCs have been shown to release interleukin 10, which could inhibit the im-
mune response but on the other hand interferon-gamma could enhance MHCII
presentation in some MSCs. Our results confirmed our hypothesis because
clonal cultures isolated from different sources of MSCs in the same animal
show differences in proliferation rate, morphology, and surface marker pre-
sentation. Mesenchymal stem cells are not immunogenic or immune-privi-
leged. Individual differences highlighted through single-cell clonal cultures
may be the key to finding universal immune-privileged MSCs for allogeneic
transplantation.
http://dx.doi.org/10.1016/j.jot.2016.06.122473
IRON SUCROSE (VENOFER) LABELLED ADIPOSE DERIVED STEM CELL BY USING
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Background: Adipose derived stem cells (ASCs) based therapy is a promising strat-
egy to promote in musculoskeletal repair. Cell differentiation ability, trophic fac-
tor and immunomodulation are considered as possible mechanisms to regenerate
new tissue. However, the cell fate after implantation is required to understand
treatment effects. In this study, we would like to investigate Iron sucrose labeling
as the tool for MSC fate. Cell immunophenotypes, cell viability, cell differentiation
ability after labelling are evaluated. Iron sucrose labelled MSCs were determined
using 3 tesla (3T) MRI in vitro
Materials and methods: Adipose-derived mesenchymal stem cells (ASCs) were iso-
lated from liposuction specimen from subcutaneous tissue. Passage 3rd ASCs were
labelled with iron sucrose by adding in basal culture media (1 mg/ml) and
